Topics

Glioblastoma | Treatment | Clinical trials | Niacin

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Niacin

Poon CC, Hagen KM, Sarkar S, Mirzaei R, Silva C, Ueno A, de Robles P, Roldan-Urgoiti G, Yong VW.
Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma.
Neurol Neuroimmunol Neuroinflamm. 2026 Feb 3;13(2):e200530. doi: 10.1212/NXI.0000000000200530. PMID: 41632924. Interventional study. ˍ